ProShare Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,082
| Closed | -$45K | – | 1726 |
|
|
2018
Q3 | $45K | Sell |
2,082
-79
| -4% | -$1.71K | ﹤0.01% | 1730 |
|
|
2018
Q2 | $93K | Sell |
2,161
-156
| -7% | -$6.71K | ﹤0.01% | 1714 |
|
|
2018
Q1 | $151K | Sell |
2,317
-381
| -14% | -$24.8K | ﹤0.01% | 1592 |
|
|
2017
Q4 | $197K | Buy |
2,698
+690
| +34% | +$50.4K | ﹤0.01% | 1646 |
|
|
2017
Q3 | $184K | Buy |
2,008
+126
| +7% | +$11.5K | ﹤0.01% | 1294 |
|
|
2017
Q2 | $124K | Sell |
1,882
-122
| -6% | -$8.04K | ﹤0.01% | 1391 |
|
|
2017
Q1 | $435K | Sell |
2,004
-521
| -21% | -$113K | ﹤0.01% | 1060 |
|
|
2016
Q4 | $234K | Buy |
2,525
+258
| +11% | +$23.9K | ﹤0.01% | 1522 |
|
|
2016
Q3 | $306K | Sell |
2,267
-417
| -16% | -$56.3K | ﹤0.01% | 1148 |
|
|
2016
Q2 | $272K | Buy |
2,684
+28
| +1% | +$2.84K | ﹤0.01% | 1251 |
|
|
2016
Q1 | $435K | Sell |
2,656
-252
| -9% | -$41.3K | 0.01% | 1059 |
|
|
2015
Q4 | $952K | Buy |
2,908
+251
| +9% | +$82.2K | 0.01% | 756 |
|
|
2015
Q3 | $857K | Sell |
2,657
-173
| -6% | -$55.8K | 0.01% | 726 |
|
|
2015
Q2 | $1.13M | Sell |
2,830
-100
| -3% | -$39.9K | 0.02% | 724 |
|
|
2015
Q1 | $1.44M | Buy |
2,930
+400
| +16% | +$197K | 0.02% | 667 |
|
|
2014
Q4 | $905K | Buy |
2,530
+58
| +2% | +$20.7K | 0.01% | 910 |
|
|
2014
Q3 | $477K | Sell |
2,472
-481
| -16% | -$92.8K | 0.01% | 1447 |
|
|
2014
Q2 | $706K | Sell |
2,953
-1,304
| -31% | -$312K | 0.01% | 1361 |
|
|
2014
Q1 | $1.09M | Buy |
4,257
+2,864
| +206% | +$732K | 0.01% | 1235 |
|
|
2013
Q4 | $276K | Sell |
1,393
-795
| -36% | -$158K | ﹤0.01% | 1187 |
|
|
2013
Q3 | $370K | Buy |
2,188
+515
| +31% | +$87.1K | 0.01% | 1723 |
|
|
2013
Q2 | $297K | Buy |
+1,673
| New | +$297K | 0.01% | 1735 |
|